N,N-DIMETHYL-3,3-DIPHENYL-1-METHYLALLYLAMINE

CC(C=C(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C

InChIKey=QZWMYBWMOFESDA-UHFFFAOYSA-N

InChI=1S/C18H21N/c1-15(19(2)3)14-18(16-10-6-4-7-11-16)17-12-8-5-9-13-17/h4-15H,1-3H3

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

PubMed

Title	Date	PubMed
Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration.	1981 Feb	7215421
Histamine release from human basophils and isolated rat mast cells induced by ketobemidone, pethidine and the spasmolytic A29.	1982 Jan	6175179
5-HT-uptake inhibition potentiates antinociception induced by morphine, pethidine, methadone and ketobemidone in rats.	1985 Sep	2865865
Premedication for day-case surgery: double-blind comparison of ketobemidone + dimethylaminodiphenylbuten (A-29) and morphine + scopolamine.	1986 Oct	3811793
Analgesic effect and bioavailability of oral ketogan given as tablets or mixture to patients with chronic pain of malignant origin.	1988	3203014

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 10:45:44 GMT 2023` Edited by `admin` on `Sat Dec 16 10:45:44 GMT 2023`
Record UNII	A6FGC19UYP
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

N,N-DIMETHYL-3,3-DIPHENYL-1-METHYLALLYLAMINE

Systematic Name

English

N,N,1-TRIMETHYL-3,3-DIPHENYLALLYLAMINE

Systematic Name

English

3-BUTEN-2-AMINE, N,N-DIMETHYL-4,4-DIPHENYL-

Systematic Name

English

A-29 LUNDBECK

Brand Name

English

ALLYLAMINE, N,N,1-TRIMETHYL-3,3-DIPHENYL-

Systematic Name

English

Code System Code Type Description

SMS_ID

100000138721